Sun.Jul 07, 2024

article thumbnail

Highmark Taps Laguna for Conversational AI

MedCity News

Through a new partnership, Highmark is integrating Laguna’s conversational AI technology into the insurer’s platform to support care managers. The post Highmark Taps Laguna for Conversational AI appeared first on MedCity News.

article thumbnail

Four drugmakers found to have breached ABPI code

pharmaphorum

Novartis, Pfizer, Otsuka and Novo Nordisk have been called out for breaching the ABPI code of practice

115
115
article thumbnail

Can Health Systems Afford to Overlook the CISO Role?

MedCity News

As a result of ever-growing cybersecurity threats, health systems are prioritizing the role of the chief information security officer, according to a consultant at WittKieffer. The post Can Health Systems Afford to Overlook the CISO Role? appeared first on MedCity News.

article thumbnail

Bulevirtide in Combination With PegInterferon Results In Undetectable Hepatitis D RNA Post-Treatment

Pharmacy Times

In the 2 mg bulevirtide (Gilead Sciences) group, 44% of individuals achieved HDV RNA that was undetectable compared with 70% in the 10 mg group.

37
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med

MedCity News

European Medicines Agency approval of Dupixent in chronic obstructive pulmonary disease makes the drug the first biologic therapy approved for treating the prevalent respiratory condition. In COPD, Dupixent addresses what’s called type 2 inflammation. The post Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med appeared first on MedCity News.

Medicine 113
article thumbnail

New Online Tracking Guidance from HHS: Staying Compliant While Not Breaking the Bank

MedCity News

How do independent physicians’ practices maintain a data-based marketing strategy while staying HIPAA compliant? The post New Online Tracking Guidance from HHS: Staying Compliant While Not Breaking the Bank appeared first on MedCity News.

article thumbnail

MedCity FemFwd: The Supreme Court’s Decision on Mifepristone

MedCity News

In this episode, we’re joined by Rabia Muqaddam, senior staff attorney at the Center for Reproductive Rights. Muqaddam discusses the Supreme Court’s recent decision that preserved access to the abortion pill mifepristone. The post MedCity FemFwd: The Supreme Court’s Decision on Mifepristone appeared first on MedCity News.

119
119